Michael Shawn Moran - 07 Jan 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
EVP, Chief Commercial Officer
Signature
/s/ Brian Cahill, Attorney-in-Fact
Issuer symbol
EGRX
Transactions as of
07 Jan 2022
Net transactions value
-$4,557
Form type
4
Filing time
11 Jan 2022, 15:42:55 UTC
Previous filing
07 Jan 2022
Next filing
01 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability $4,557 -90 -0.4% $50.63 22,667 07 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations.